Latest filings (excl ownership)
EFFECT
Notice of effectiveness
11 Dec 17
POS AM
Prospectus update (post-effective amendment)
7 Dec 17
S-8 POS
Registration of securities for employees (post-effective amendment)
7 Dec 17
15F-12G
Securities registration termination (foreign)
6 Dec 17
6-K
Current report (foreign)
9 Nov 17
6-K
Current report (foreign)
8 Aug 17
8-K
Other Events
26 Jul 17
8-K
Submission of Matters to a Vote of Security Holders
26 May 17
8-K
Entry into a Material Definitive Agreement
25 May 17
10-Q
2017 Q1
Quarterly report
10 May 17
8-K
Results of Operations and Financial Condition
10 May 17
DEF 14A
Definitive proxy
27 Apr 17
424B3
Prospectus supplement
5 Apr 17
PRE 14A
Preliminary proxy
5 Apr 17
10-K
2016 FY
Annual report
15 Mar 17
8-K
Departure of Directors or Certain Officers
24 Feb 17
8-K
Regulation FD Disclosure
21 Feb 17
8-K
Results of Operations and Financial Condition
14 Feb 17
8-K
Entry into a Material Definitive Agreement
18 Jan 17
8-K
Entry into a Material Definitive Agreement
10 Jan 17
8-K
Acucela Secures Option to Exclusively Acquire Novel Retinal Technology
14 Dec 16
EFFECT
Notice of effectiveness
9 Dec 16
POS AM
Prospectus update (post-effective amendment)
7 Dec 16
S-8
Registration of securities for employees
7 Dec 16
8-K
Results of Operations and Financial Condition
6 Dec 16
8-K
Changes in Registrant's Certifying Accountant
6 Dec 16
15-12G
Securities registration termination
5 Dec 16
8-K12G3
Notification of registration of securities
2 Dec 16
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 16
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 16
S-8 POS
Registration of securities for employees (post-effective amendment)
2 Dec 16
10-Q
2016 Q3
Quarterly report
4 Nov 16
8-K
Results of Operations and Financial Condition
4 Nov 16
425
Business combination disclosure
28 Oct 16
8-K
Acucela Issues Notice of Listing Approval of Kubota Pharmaceutical Holdings
28 Oct 16
425
Business combination disclosure
19 Oct 16
8-K
Acucela Issues Notice of Resolutions of the Annual Meeting of Shareholders
19 Oct 16
425
Business combination disclosure
15 Sep 16
8-K
Other Events
15 Sep 16
DEFM14A
Proxy related to merger
15 Sep 16
Latest ownership filings
4
LUKAS SCHEIBLER
18 Jul 17
4
EDWARD H DANSE
5 Jul 17
4
JOHN E GEBHART
5 Jul 17
4
LUKAS SCHEIBLER
20 Jun 17
4
EDWARD H DANSE
2 Jun 17
4
JOHN E GEBHART
2 Jun 17
4
LUKAS SCHEIBLER
18 May 17
4
EDWARD H DANSE
2 May 17
4
JOHN E GEBHART
2 May 17
4
LUKAS SCHEIBLER
17 Apr 17
4
EDWARD H DANSE
4 Apr 17
4
JOHN E GEBHART
4 Apr 17
4
LUKAS SCHEIBLER
20 Mar 17
3/A
Initial statement of insider ownership (amended)
13 Mar 17
3
Initial statement of insider ownership
8 Mar 17
4
Change in insider ownership
8 Mar 17
4
JOHN E GEBHART
2 Mar 17
4
EDWARD H DANSE
2 Mar 17
4
LUKAS SCHEIBLER
21 Feb 17
SC 13D/A
Beneficial ownership report (amended)
17 Feb 17
4
Change in insider ownership
8 Feb 17
4
JOHN E GEBHART
3 Feb 17
4
EDWARD H DANSE
3 Feb 17
4
LUKAS SCHEIBLER
20 Jan 17
SC 13D/A
Kubota Pharmaceutical Holdings Co LTD
11 Jan 17
4
Change in insider ownership
10 Jan 17
4
EDWARD H DANSE
6 Jan 17
4
JOHN E GEBHART
6 Jan 17
4
JOHN E GEBHART
27 Dec 16
4
LUKAS SCHEIBLER
27 Dec 16
4
EDWARD H DANSE
19 Dec 16
4
LUKAS SCHEIBLER
21 Nov 16
4
LUKAS SCHEIBLER
15 Nov 16
4
JOHN E GEBHART
2 Nov 16
4
EDWARD H DANSE
2 Nov 16
4
LUKAS SCHEIBLER
18 Oct 16
4
EDWARD H DANSE
4 Oct 16
4
JOHN E GEBHART
4 Oct 16
4
JOHN E GEBHART
30 Sep 16
4
LUKAS SCHEIBLER
20 Sep 16